Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
Diclofenac sodium
Laboratoires Thea
S01BC; S01BC03
Diclofenac sodium
1 milligram(s)/millilitre
Eye drops, solution
Product subject to prescription which may be renewed (B)
Antiinflammatory agents, non-steroids; diclofenac
Marketed
2002-05-03
LEAFLET VOLTAROL® OPHTHA MULTIDOSE 1MG/ML EYE DROPS SOLUTION DICLOFENAC SODIUM READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Voltarol Ophtha Multidose Eye Drops is and what it is used for 2. What you need to know before you use Voltarol Ophtha Multidose Eye Drops 3. How to use Voltarol Ophtha Multidose Eye Drops 4. Possible side effects 5. How to store Voltarol Ophtha Multidose Eye Drops 6. Contents of the pack and other information 1. WHAT VOLTAROL OPHTHA MULTIDOSE EYE DROPS IS AND WHAT IT IS USED FOR Voltarol Ophtha Multidose Eye Drops contains the active substance diclofenac sodium. This is one of a group of medicines called non-steroidal anti-inflammatory drugs. These drops are used to help keep the pupil open during eye surgery; to treat inflammation of the eye associated with cataract surgery or after laser surgery for glaucoma; to treat pain and discomfort associated with excimer laser surgery or accidental non-penetrating injury to the eye; to provide relief from the ocular signs and symptoms of Seasonal Allergic Conjunctivitis (hayfever). Doctors sometimes prescribe these eye drops for other purposes. Consult your doctor if this applies to you. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE VOLTAROL OPHTHA MULTIDOSE EYE DROPS Do not use Voltarol Ophtha Multidose Eye Drops: • If you are allergic to diclofenac sodium or any of the other ingredients of this medicine (listed in section 6). • If you have had an allergic reaction, skin rash, blocked nose or wheezing after taking Lees het volledige document
Health Products Regulatory Authority 30 September 2020 CRN009TW5 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Voltarol Ophtha Multidose 1mg/ml Eye Drops Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Diclofenac Sodium 1 mg/ml. Excipient with known effect: benzalkonium chloride (0.05 mg/ml) For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops solution. (Eye drops) A clear, colourless, odourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For pre and post operative prevention of post-surgery aphakic cystoid macular oedema associated with cataract lens extraction and intraocular lens implantation. In inhibition of intraoperative miosis. In post-operative inflammation in cataract surgery and other surgical interventions. In non-infected inflammatory conditions of the anterior segment of the eye. In inflammation following trauma and non-penetrating injuries (in combination with local anti-infective treatment). Control of ocular pain and discomfort associated with corneal epithelial defects after excimer PRK surgery. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS Pre-operatively: 1 drop four times during the 2 hours before surgery. Post-operatively: 1 drop four times daily for up to 12 weeks. Post PRK pain: 1 drop 2 times in the hour prior to surgery, one drop 2 times five minutes apart immediately after PRK surgery and then post-operatively 1 drop every 2-5 hours while awake for up to 24 hours. Other indications: 1 drop 4 to 5 times daily depending upon the severity of the disease. CHILDREN Paediatric Use: Voltarol Ophtha is not indicated for use in children. Paediatric experience is limited to a few published clinical studies in strabismus surgery. ELDERLY There is no indication that dosage needs to be modified for the elderly. The dispenser remains sterile until the original closure is broken. Patients must be instructed to avoid allowing the tip of the dispensing container to contact the eye or surrounding structures as this may co Lees het volledige document